Skip to main content
TipRanks
Go Ultimate75% OFF

Pelthos Therapeutics (PTHS) Stock Forecast & Price Target

77 Followers
See the Price Targets and Ratings of:

PTHS Analyst Ratings

Strong Buy
6Ratings
5Buy1Hold0Sell
Based on 6 analysts giving stock ratings to Pelthos Therapeutics in the past 3 months

PTHS Stock 12 Month Forecast

$47.00▲(531.72% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for Pelthos Therapeutics in the last 3 months. The average price target is $47.00 with a high forecast of $60.00 and a low forecast of $21.00. The average price target represents a 531.72% change from the last price of $7.44.
Highest Price Target$60.00Average Price Target$47.00Lowest Price Target$21.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for PTHS
Price TargetArticle
Alliance Global Partners―hold―Downgraded11/13/26
Piper Sandler$48→$21buy182.26%UpsideReiterated11/13/26
Oppenheimer$64→$59buy693.01%UpsideReiterated11/13/26
H.C. Wainwright$60buy706.45%UpsideReiterated11/13/26
Roth MKM$55buy639.25%UpsideReiterated11/13/26
Lake Street$50→$40buy437.63%UpsideReiterated10/12/26
Cantor Fitzgerald$50buy572.04%UpsideInitiated04/01/26
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Pelthos Therapeutics

3 Months
Success Rate3/6 ratings generated profit
50%
Average Return
-0.92%

Copying Jonathan Aschoff's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -0.92% per trade.

1 Year
Jeff Jones
Jeff JonesOppenheimer
Success Rate0/7 ratings generated profit
0%
Average Return
-56.14%

Copying Jeff Jones's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -56.14% per trade.

2 Years
Brandon Folkes
Brandon FolkesH.C. Wainwright
Success Rate0/6 ratings generated profit
0%
Average Return
-59.98%

Copying Brandon Folkes's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -59.98% per trade.

PTHS Analyst Recommendation Trends

010203040Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for PTHS
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy1716151513
Buy00000
Hold00001
Sell00000
Strong Sell00000
total1716151514

In the current month, PTHS has received 13 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. PTHS average Analyst price target in the past 3 months is 47.00.

PTHS Financial Forecast

$-8$-6.25$-4.5$-2.75$-1Q1 2026Q3 2026Q4 2026
High$-1.07
Consensus$-2.69
Low$-4.93

PTHS Earnings Forecast

Next quarter’s earnings estimate for PTHS is -$2.69 with a range of -$4.93 to -$1.07. The previous quarter’s EPS was -$2.04. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.

$9.4M$11.4M$13.4M$15.5M$17.5MQ1 2026Q3 2026Q4 2026
High$17.5M
Consensus$16.2M
Low$13.4M

PTHS Sales Forecast

Next quarter’s sales forecast for PTHS is $16.22M with a range of $13.43M to $17.50M. The previous quarter’s sales results were $15.39M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

PTHS Stock Forecast FAQ

What is PTHS’s average 12-month price target, according to analysts?
Based on analyst ratings, Pelthos Therapeutics’s 12-month average price target is $47.00.
What is PTHS’s upside potential, based on the analysts’ average price target?
Pelthos Therapeutics has 531.72% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PTHS a Buy, Sell or Hold?
Pelthos Therapeutics has a consensus rating of Strong Buy which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.
What is Pelthos Therapeutics’s price target?
The average price target for Pelthos Therapeutics is $47.00. This is based on 6 12-month price targets, issued in the past 3 months. The highest analyst price target is $60.00, the lowest forecast is $21.00. The average price target represents a 531.72% increase from the current price of $7.44.
What do analysts say about Pelthos Therapeutics?
Pelthos Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Street analysts.
How can I buy shares of PTHS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.